108 related articles for article (PubMed ID: 7868663)
1. Ovarian stimulation in an infertile patient with growth hormone-deficient Oliver-Mcfarlane syndrome.
Shaker AG; Fleming R; Jamieson ME; Yates RW; Coutts JR
Hum Reprod; 1994 Nov; 9(11):1997-8. PubMed ID: 7868663
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
Homburg R; Levy T; Ben-Rafael Z
Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and ovulation: is there an indication for treatment of infertile women with growth hormone?
Jacobs HS
Horm Res; 1992; 38 Suppl 1():14-21. PubMed ID: 1295808
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the threshold of ovarian sensitivity to human menopausal gonadotrophin stimulation and in-vitro fertilization treatment outcome.
Shulman A; Ghetler Y; Fejgin M; Kaneti H; Weinstein S; Beyth Y; Ben-Nun I
Hum Reprod; 1995 Dec; 10(12):3198-201. PubMed ID: 8822443
[TBL] [Abstract][Full Text] [Related]
5. The influence of ovarian follicular activity on late proliferative phase serum IGFBP-1 in down-regulated assisted conception cycles.
Arthur ID; Anthony FW; Masson GM; Thomas EJ
Hum Reprod; 1994 Aug; 9(8):1417-20. PubMed ID: 7527420
[TBL] [Abstract][Full Text] [Related]
6. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
[TBL] [Abstract][Full Text] [Related]
7. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
8. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone.
Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID
Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
10. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T
Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
[TBL] [Abstract][Full Text] [Related]
11. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders.
Shaker AG; Fleming R; Jamieson ME; Yates RW; Coutts JR
Fertil Steril; 1992 Nov; 58(5):919-23. PubMed ID: 1426376
[TBL] [Abstract][Full Text] [Related]
12. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
[TBL] [Abstract][Full Text] [Related]
13. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
14. Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing in-vitro fertilization and embryo transfer with ovarian stimulation.
Potashnik G; Lunenfeld E; Shwartz I; Glezerman M; Roberts CT; LeRoith D; Sharoni Y; Levy J
Hum Reprod; 1995 May; 10(5):1065-9. PubMed ID: 7657742
[TBL] [Abstract][Full Text] [Related]
15. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
16. A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization.
Simon A; Benshushan A; Shushan A; Zajicek G; Dorembus D; Lewin A; Laufer N
Hum Reprod; 1994 Oct; 9(10):1813-7. PubMed ID: 7844208
[TBL] [Abstract][Full Text] [Related]
17. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
18. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response in consecutive cycles of ovarian stimulation in normally ovulating women.
Ahmed Ebbiary NA; Morgan C; Martin K; Afnan M; Newton JR
Hum Reprod; 1995 Mar; 10(3):536-43. PubMed ID: 7782429
[TBL] [Abstract][Full Text] [Related]
20. Another look at co-treatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders.
Levy T; Limor R; Villa Y; Eshel A; Eckstein N; Vagman I; Lidor A; Ayalon D
Hum Reprod; 1993 Jun; 8(6):834-9. PubMed ID: 8345071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
